Bill

Bill > H2071


MA H2071

MA H2071
Relative to opioid drug manufacturer assessments


summary

Introduced
03/29/2021
In Committee
03/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislation to establish an opioid treatment and addiction prevention fund. Mental Health, Substance Use and Recovery.

AI Summary

This bill establishes an Opioid Treatment and Addiction Prevention Fund, to be funded by an assessment on manufacturers of opioid drugs. The assessment is calculated based on the manufacturer's annual distribution and dispensing of opioid drugs in the Commonwealth, with a total annual cap of $15 million. The funds will be used for prevention, treatment, management, and research related to opioid addiction, as well as research to reduce barriers to effective pain management alternatives to opioid drugs. The Department of Public Health is required to promulgate regulations to implement the bill within 180 days of its effective date, and Section 1 of the bill will take effect on June 30, 2022.

Committee Categories

Health and Social Services

Sponsors (4)

Last Action

Accompanied a study order, see H5194 (on 09/06/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...